Status:
TERMINATED
Comparison Between 4 Different Nasal Dilators
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Incompetence of Nasal Valve
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Several nasal dilators are currently commercially available, and can be applied endonasally (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison between these dilat...
Detailed Description
Several nasal dilators are currently commercially available, and can be applied endonasally (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison between these dilat...
Eligibility Criteria
Inclusion
- Patients with nasal obstruction due to external nasal valve problems and with positive Cottle sign.
- Age \> 18 and \< 60 years. Ability to give reliable information and written informed consent.
Exclusion
- Patients with nasal obstruction due to other endonasal anatomic deformities besides external nasal valve dysfunction.
- Patients with rhinosinusitis and/or nasal polyps evaluated by nasal endoscopy. Patients with chronic lower airway disease like severe asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and/or other conditions that interfere with the generation of a reliable Peak Nasal Inspiratory Flow (PNIF) result.
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02196389
Start Date
January 1 2014
End Date
August 18 2018
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000